Results 61 to 70 of about 56,153 (181)

Preoperative physiotherapy for improving the reserve capacity in a patient with esophageal cancer and frailty: A case report

open access: yesPhysiotherapy Research International, Volume 29, Issue 4, October 2024.
Abstract Introduction Frailty is significantly correlated with a higher incidence of medical complications during hospitalization after esophagectomy. As frailty is thought to be a reversible condition, improving the reserve capacity through preoperative physical therapy is expected to reduce the risk of postoperative pulmonary complications (PPCs ...
Yusuke Takahashi   +6 more
wiley   +1 more source

Comparative evaluation of the efficacy and safety of olopatadine and sodium cromoglycate eye drops [PDF]

open access: yes, 2020
Background: Allergic conjunctivitis is the commonest ocular morbidity worldwide. Understanding of underlying mechanisms is important to choose the best therapy.
Sinha, Arun Kumar, Kumar, Sunil
core   +1 more source

A comparative study of efficacy and tolerability of bepotastine besilate (1.5%) and olopatadine hydrochloride (0.1%) eye drops in allergic conjunctivitis in a tertiary care hospital of the southern part of India

open access: yesAsian Journal of Medical Sciences
Background: Allergic conjunctivitis is increasing with the rise in the levels of allergens. Drug therapy is usually needed in addition to avoidance of general allergens to treat this condition.
Sudipto Chatterjee   +3 more
doaj   +1 more source

Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis

open access: yesVeterinary Ophthalmology, Volume 27, Issue 5, Page 396-405, September 2024.
Abstract Objective The objective of the study was to evaluate the efficacy of a once a day, over the counter antihistamine eye drop, 0.7% olopatadine hydrochloride, in treating or preventing experimentally induced allergic conjunctivitis in dogs.
Esther T. Mamo   +2 more
wiley   +1 more source

A pharmacoeconomic study of olopatadine hydrochloride 0.1% eye drops and bepotastine besilate 1.5% eye drops in the management of allergic conjunctivitis: A cost-effectiveness analysis

open access: yesAsian Journal of Medical Sciences
Background: Allergic conjunctivitis (AC) affects 10–20% of the Indian population, necessitating cost-effective treatment strategies. Aims and Objectives: We aimed to evaluate the comparison between the pharmacoeconomic profiles of olopatadine ...
Sudipto Chatterjee   +3 more
doaj   +1 more source

A prospective study of efficacy and safety of olopatadine versus azelastine in allergic conjunctivitis at a tertiary care hospital [PDF]

open access: yes, 2017
Background: Allergic conjunctivitis, an ocular surface inflammatory disease with significant social and economic impact affects approximately 25% of the general population.
Vijayalakshmi, .   +5 more
core   +1 more source

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment [PDF]

open access: yes, 2017
Takanori Mizoguchi,1 Mineo Ozaki,2 Nobuchika Ogino3 1Mizoguchi Eye Clinic, Ophthalmology, Sasebo, Japan; 2Ozaki Eye Hospital, Ophthalmology, Miyazaki, Japan; 3Nishigaki Eye Clinic, Ophthalmology, Nagoya, Japan Purpose: To evaluate the efficacy and ...
Ozaki M   +5 more
core   +1 more source

ALLERGIC EYE DISEASES IN CHILDREN. MODERN VIEW ON PATHOGENESIS AND TREATMENT

open access: yesOftalʹmologiâ, 2017
The prevalence off allergic diseases has  been  significantly increased among  adults  and children during last 30-40 years. International study has  shown  that  the  frequency  of atopy  in developed  countries, including Russia,   is higher  than  in ...
E. Y. Markova   +2 more
doaj   +1 more source

PHARMACOKINETIC STUDY OF OLOPATADINE 10 MG EXTENDED RELEASE TABLET IN COMPARISON WITH OLOPATADINE 5 MG IMMEDIATE RELEASE TABLET IN INDIAN POPULATION [PDF]

open access: yes, 2021
Objective: This study was designed to assess the pharmacokinetics of single dose of olopatadine hydrochloride 10 mg extended release (ER) tablet of Ranbaxy laboratories limited (two test formulations) with two doses of Allelock® 5 mg immediate release ...
MARWAH, AMIT   +3 more
core   +1 more source

Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R

open access: yesAllergy, Asthma & Clinical Immunology, 2020
MP-AzeFlu is relatively new a pharmaceutical drug used in the treatment of allergic rhinitis. It is comprised of azelastine hydrochloride (AZE), a potent histamine-H1-receptor antagonist and fluticasone propionate (FP), corticosteroid.
Sandra Ekstedt   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy